- Home
- ESP vs TLSA Comparison
ESP vs TLSA Comparison
Compare ESP & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESP | TLSA |
|---|---|---|
| Founded | 1928 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.8M | 182.7M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | ESP | TLSA |
|---|---|---|
| Price | $45.32 | $1.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.7K | ★ 456.5K |
| Earning Date | 02-11-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | ★ 28.72 | N/A |
| EPS | ★ 3.16 | N/A |
| Revenue | ★ $42,600,530.00 | N/A |
| Revenue This Year | $9.16 | N/A |
| Revenue Next Year | $5.68 | N/A |
| P/E Ratio | $13.60 | ★ N/A |
| Revenue Growth | ★ 4.90 | N/A |
| 52 Week Low | $24.85 | $0.63 |
| 52 Week High | $55.00 | $2.60 |
Technical Indicators
Market Signals| Indicator | ESP | TLSA |
|---|---|---|
| Relative Strength Index (RSI) | 65.66 | 40.98 |
| Support Level | $42.38 | $1.36 |
| Resistance Level | $44.33 | $1.62 |
| Average True Range (ATR) | 1.82 | 0.17 |
| MACD | 0.22 | -0.02 |
| Stochastic Oscillator | 85.32 | 46.15 |
Price Performance
Historical ComparisonAbout ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.